General & Plastic Surgery Devices - Lithuania

  • Lithuania
  • The General & Plastic Surgery Devices market market in Lithuania is anticipated to witness a substantial increase in revenue, with projections indicating it will reach US$17.44m by the year 2024.
  • Furthermore, it is expected to exhibit a steady annual growth rate of 4.99% (CAGR 2024-2029), ultimately leading to a market volume of US$22.25m by 2029.
  • When comparing in Lithuania to other countries on a global scale, it is worth noting that the United States is projected to generate the highest revenue, amounting to a staggering US$9,844.00m in 2024.
  • Lithuania is experiencing a growing demand for advanced plastic surgery devices, reflecting the country's increasing emphasis on aesthetic procedures and medical tourism.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in Lithuania has witnessed significant growth in recent years, driven by customer preferences for advanced and minimally invasive surgical procedures.

Customer preferences:
Lithuanian customers have shown a growing preference for advanced surgical devices and techniques in the field of general and plastic surgery. This is mainly due to the increasing awareness and demand for minimally invasive procedures, which offer shorter recovery times, reduced scarring, and lower risk of complications. The demand for devices such as laser systems, robotic surgical systems, and advanced imaging technologies has been on the rise as they enable surgeons to perform complex procedures with greater precision and efficiency.

Trends in the market:
One of the key trends in the General & Plastic Surgery Devices market in Lithuania is the adoption of 3D printing technology in the production of customized implants and prosthetics. This technology allows for the creation of patient-specific devices that fit perfectly and enhance the overall surgical outcomes. The use of 3D printing also reduces the manufacturing time and costs, making it an attractive option for both patients and healthcare providers. Another trend in the market is the increasing demand for non-surgical cosmetic procedures. This includes treatments such as injectables, dermal fillers, and chemical peels, which offer temporary enhancements without the need for invasive surgery. The popularity of these procedures can be attributed to their quick results and minimal downtime, making them a preferred choice for individuals seeking aesthetic improvements.

Local special circumstances:
Lithuania has a well-developed healthcare system, with a high level of expertise in the field of general and plastic surgery. The country is known for its skilled surgeons and advanced medical facilities, which attract patients from both within the country and abroad. The relatively lower costs of surgical procedures in Lithuania compared to other European countries also contribute to the growth of the General & Plastic Surgery Devices market.

Underlying macroeconomic factors:
The growing economy of Lithuania has played a significant role in the development of the General & Plastic Surgery Devices market. The increasing disposable income of the population has made advanced surgical procedures more affordable and accessible. Additionally, the government has implemented policies to promote medical tourism, attracting international patients who seek high-quality healthcare services at competitive prices. In conclusion, the General & Plastic Surgery Devices market in Lithuania is experiencing growth due to the increasing customer preferences for advanced surgical techniques, such as minimally invasive procedures and 3D printing technology. The demand for non-surgical cosmetic procedures is also on the rise. The country's well-developed healthcare system, skilled surgeons, and relatively lower costs of surgical procedures contribute to the market's growth. The growing economy and government initiatives to promote medical tourism further support the expansion of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)